Rock Springs Capital Management’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
2022
Q3
$479K Sell
2022
Q2
$1.67M Buy
2022
Q1
$3.45M Buy
2021
Q4
$6.74M Buy
2021
Q3
$5.73M Hold
2021
Q2
$6.86M Buy
2021
Q1
$5.38M Buy
2020
Q4
$4.42M Buy
2020
Q3
$4.61M Buy
2020
Q2
$5.26M Buy
2020
Q1
$3.72M Hold
2019
Q4
$6.87M Sell
2019
Q3
$5.91M Sell
2019
Q2
$18.7M Buy
2019
Q1
$10.8M Buy
2018
Q4
$2.58M Buy